Eli Lilly added additional affordability options for patients with diabetes who use certain insulin products.
Diabetes Type 2
As the price of insulin has skyrocketed, patients with diabetes are struggling to pay for their medication.
Due to ongoing insulin affordability challenges, Novo Nordisk is offering new cost assistance options for patients with diabetes.
A set of performance measures for older adults with type 2 diabetes at greater risk for hypoglycemia published by the Endocrine Society and Avalere Health.
Based upon results from a military population study presented at ASHP 2019.
Patients with type 2 diabetes should keep taking their medication.
Previously approved for IV infusion.
Reduces risk for heart failure and cardiovascular disease hospitalizations.
As people with type 2 diabetes age, the risks of insulin use can outweigh its benefits, creating the need for increased provider and patient education.
Noteworthy diabetes management products and updates making waves this year.